Bluejay Diagnostics Inc (BJDX) - News Archive

Bluejay Diagnostics: A Strategic Shift Forward in Medical TechnologyIn a bold maneuver aimed at bolstering its market position, Bluejay Diagnostics, Inc. (NASDAQ: BJDX) has announced a significant reverse stock split of...

Bluejay Diagnostics Inc (NASDAQ: BJDX) has recently encountered a sell-off in its shares, raising concerns about the company s financial health. This article explores the reasons behind this decline, including the negat...

Bluejay Diagnostics, a medical technology company specializing in developing rapid diagnostics for critical care settings, has successfully closed a firm commitment underwritten public offering. The offering is expected...

In a recent press release, Bluejay Diagnostics, a leading medical technology company, announced the successful pricing of their underwritten public offering. With a firm commitment, the company is set to receive approxi...

Interpreting IL-6 as a Predictor of Mortality in Sepsis Patients: Insights from the SYMON-I Study Sepsis, a life-threatening condition resulting from the body s dysregulated response to infection, presents a significant...

Acton, Mass., June 17, 2024 - Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a prominent medical technology company focused on improving patient outcomes through rapid diagnostics, has recently announced significant changes...

Bluejay Diagnostics, Inc. (NASDAQ: BJDX) recently announced the pricing of a public offering of its common stock and warrants, aiming to raise $3.5 million. The medical technology company, known for developing rapid dia...

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)Bluejay Diagnostics, a leading biotechnology company, has recently made an exciting a...